Literature DB >> 6121757

Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin.

P A Mickelsen, E Blackman, P F Sparling.   

Abstract

The ability of 107 Neisseria isolates to compete for iron with human lactoferrin (LF) was examined. Each of 15 meningococci, 53% of 59 selected gonococci, and 24% of 33 commensal Neisseria could use LF-bound iron for growth. Isolates which could not obtain iron from LF were growth inhibited when sufficient LF was added to defined agar medium to bind available free iron. No difference was observed in the ability of colony type 1 and colony type 4 gonococci of the same strain to compete with LF for iron. LF was growth inhibitory for 50% of 22 disseminated disease isolates (DGI strains) and 51% of 35 local urogenital disease isolates (UGI strains). Only 14% of gonococcal isolates requiring arginine, hypoxanthine, and uracil for growth were able to compete with LF for iron, whereas 87% of all other gonococcal isolates could do so (P less than 0.005). Ability to obtain iron from LF does not appear to be required for survival of Neisseria on mucosal surfaces, nor essential for invasion of the bloodstream by gonococci. However, ability to utilize LF as a source of iron may contribute to differences in pathogenicity among certain gonococcal isolates.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6121757      PMCID: PMC351134          DOI: 10.1128/iai.35.3.915-920.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Nutritional profiles of Neisseria gonorrhoeae, Neisseria meningitidis, and Neisseria lactamica in chemically defined media and the use of growth requirements for gonococcal typing.

Authors:  B W Catlin
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

2.  Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus.

Authors:  P L Masson; J F Heremans; J J Prignot; G Wauters
Journal:  Thorax       Date:  1966-11       Impact factor: 9.139

3.  Molecular weight, single-chain structure and amino acid composition of human lactoferrin.

Authors:  P Querinjean; P L Masson; J F Heremans
Journal:  Eur J Biochem       Date:  1971-06-11

4.  Inhibition of Escherichia coli by bovine colostrum and post-colostral milk. II. The bacteriostatic effect of lactoferrin on a serum susceptible and serum resistant strain of E. coli.

Authors:  B Reiter; J H Brock; E D Steel
Journal:  Immunology       Date:  1975-01       Impact factor: 7.397

5.  Disseminated gonococcal infection.

Authors:  K K Holmes; G W Counts; H N Beaty
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

6.  Autolysis of Neisseria gonorrhoeae.

Authors:  B H Hebeler; F E Young
Journal:  J Bacteriol       Date:  1975-05       Impact factor: 3.490

7.  Disseminated gonococcal infections caused by Neisseria gonorrhoeae with unique nutritional requirements.

Authors:  J S Knapp; K K Holmes
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

8.  Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro.

Authors:  D S Kellogg; I R Cohen; L C Norins; A L Schroeter; G Reising
Journal:  J Bacteriol       Date:  1968-09       Impact factor: 3.490

9.  Lactoferrin, an iron-binding protein in neutrophilic leukocytes.

Authors:  P L Masson; J F Heremans; E Schonne
Journal:  J Exp Med       Date:  1969-09-01       Impact factor: 14.307

10.  The involvement of lactoferrin in the hyposideremia of acute inflammation.

Authors:  J L Van Snick; P L Masson; J F Heremans
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  79 in total

1.  Identification of discrete domains within gonococcal transferrin-binding protein A that are necessary for ligand binding and iron uptake functions.

Authors:  I C Boulton; M K Yost; J E Anderson; C N Cornelissen
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Specific ligand binding attributable to individual epitopes of gonococcal transferrin binding protein A.

Authors:  Heather P Masri; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Gonococcal genes encoding transferrin-binding proteins A and B are arranged in a bicistronic operon but are subject to differential expression.

Authors:  C Ronpirin; A E Jerse; C N Cornelissen
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 4.  Bacterial transferrin receptors--structure, function and contribution to virulence.

Authors:  P Williams; E Griffiths
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

Review 5.  Iron acquisition and the pathogenesis of meningococcal and gonococcal disease.

Authors:  J P van Putten
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

6.  A doctor's dilemma: choices amidst change.

Authors:  P Frederick Sparling
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

7.  Beyond the Crystal Structure: Insight into the Function and Vaccine Potential of TbpA Expressed by Neisseria gonorrhoeae.

Authors:  Devin R Cash; Nicholas Noinaj; Susan K Buchanan; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

8.  Role of extracellular iron in the action of the quinone antibiotic streptonigrin: mechanisms of killing and resistance of Neisseria gonorrhoeae.

Authors:  M S Cohen; Y Chai; B E Britigan; W McKenna; J Adams; T Svendsen; K Bean; D J Hassett; P F Sparling
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

9.  Human calprotectin affects the redox speciation of iron.

Authors:  Toshiki G Nakashige; Elizabeth M Nolan
Journal:  Metallomics       Date:  2017-08-16       Impact factor: 4.526

10.  Binding and accumulation of hemin in Neisseria gonorrhoeae.

Authors:  P J Desai; R Nzeribe; C A Genco
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.